Search results

The National Deuteration Facility offers access to deuterated molecules prepared by both in vivo biodeuteration and chemical deuteration techniques.

Voucher scheme accelerating medical research

The Australian Synchrotron is a source of powerful X-rays and infrared radiation that can be used for a wide range of scientific and technical purposes. Synchrotron X-rays are millions of times brighter than those produced by conventional X-ray machines in laboratories and hospitals.

Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.

A dedicated team of radiation specialists from the Australian Nuclear Science and Technology Organisation (ANSTO) are behind the successful detection and rapid retrieval of a missing radioactive source in outback Western Australia.

Ongoing media statements relating to nuclear medicine production.

Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

This state-of-the-art metastable-exchange optical-pumping helium-3 polarising system enables polarisation-analysis experiments on five of our existing instruments.

See details of previously published customer updates from our Health products team. 

During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).

The Titan Krios cryo-electron microscope reveals the inner workings of life at the cellular level.

The ARC Centre of Excellence (CoE) for Green Electrochemical Transformation of Carbon Dioxide, GETCO2, will support innovative approaches to carbon capture.

The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.

ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.